Markers in Blood and Spinal Fluid Show Promise

Early Detection of Alzheimer's With the continued aging of the population and the growing epidemic of Alzheimer's, early detection of the disease is crucial for risk assessment, testing new therapies, and eventual early intervention with better drugs, once they are developed. Four studies bring us closer to that goal of early detection by describing advances in biomarkers.

1. Blood Test on White Blood Cells May Be Useful for Early Detection of Alzheimer's
2. Spinal Fluid Marker Tracks Brain Amyloid, May Identify Alzheimer's Before Symptoms
3. Brain Enzyme May Improve Alzheimer's Risk Assessment and Early Detection
4. Improved Amyloid Imaging Agents for PET in Development